The purpose of this study is to assess the safety and efficacy of multiple study interventions including novel-novel combinations or novel agents in combination with standard therapy for the treatment of metastatic NSCLC.
The purpose of this study is to assess the safety and efficacy of multiple study interventions including novel-novel combinations or novel agents in combination with standard therapy for the treatment of metastatic NSCLC.
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
-
Research Site, Phoenix, Arizona, United States, 85054
Research Site, Santa Rosa, California, United States, 95403
Research Site, Jacksonville, Florida, United States, 32224
Research Site, Baltimore, Maryland, United States, 21201
Research Site, Detroit, Michigan, United States, 48202
Research Site, Rochester, Minnesota, United States, 55905
Research Site, Cleveland, Ohio, United States, 44106
Research Site, Providence, Rhode Island, United States, 02903
Research Site, Tyler, Texas, United States, 75708
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
AstraZeneca,
2028-12-29